Skip Navigation

Publication Detail

Title: Obesogenic Endocrine Disrupting Chemicals: Identifying Knowledge Gaps.

Authors: Veiga-Lopez, Almudena; Pu, Yong; Gingrich, Jeremy; Padmanabhan, Vasantha

Published In Trends Endocrinol Metab, (2018 Sep)

Abstract: Endocrine disrupting chemicals (EDCs) are compounds that are part of everyday consumer products and industrial manufacturing processes. EDCs can interfere with the endocrine system, including the adipose tissue. Accumulating evidence from epidemiological, animal, and in vitro studies demonstrates that EDCs can alter body weight, adipose tissue expansion, circulating lipid profile, and adipogenesis, with some resulting in transgenerational effects. These outcomes appear to be mediated through multiple mechanisms, from nuclear receptor binding to epigenetic modifications. A better understanding of the signaling pathways via which these EDCs contribute to an obesogenic phenotype, the interaction amongst complex mixtures of obesogenic EDCs, and the risks they pose relative to the obesity epidemic are still needed for risk assessment and development of prevention strategies.

PubMed ID: 30017741 Exiting the NIEHS site

MeSH Terms: Animals; Endocrine Disruptors; Humans; Obesity/chemically induced*; Signal Transduction*

to Top